These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24909062)

  • 21. Different refractive errors in triplets with retinopathy of prematurity treated with bevacizumab.
    Tseng CC; Chen SN; Hwang JF; Lin CJ
    J Pediatr Ophthalmol Strabismus; 2012 Aug; 49 Online():e41-3. PubMed ID: 22881829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.
    Harder BC; Schlichtenbrede FC; von Baltz S; Jendritza W; Jendritza B; Jonas JB
    Am J Ophthalmol; 2013 Jun; 155(6):1119-1124.e1. PubMed ID: 23490192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable outcomes in the treatment of aggressive posterior retinopathy of prematurity.
    Sahinoglu-Keskek N; Akkoyun I; Torer B
    Eur J Ophthalmol; 2021 Jan; 31(1):179-183. PubMed ID: 31718282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.
    Flavahan PW; Lavy TE; Wykes W
    Scott Med J; 2013 Aug; 58(3):130-2. PubMed ID: 23960050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.
    Rabinowitz R; Priel A; Rosner M; Pri-Chen S; Spierer A
    Curr Eye Res; 2012 Jul; 37(7):624-9. PubMed ID: 22578253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apelin in epiretinal fibrovascular membranes of patients with retinopathy of prematurity and the changes after intravitreal bevacizumab.
    Zhang Y; Jiang YR; Lu Q; Yin H; Tao Y
    Retina; 2013 Mar; 33(3):613-20. PubMed ID: 23296045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab.
    Snyder LL; Garcia-Gonzalez JM; Shapiro MJ; Blair MP
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):280-3. PubMed ID: 26985803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultra-low dose of intravitreal bevacizumab in the treatment of retinopathy of prematurity.
    Connor AJ; Papastavrou VT; Hillier RJ; Shafiq A
    J Pediatr Ophthalmol Strabismus; 2015 Apr; 52 Online():e20-1. PubMed ID: 25942065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab.
    Ittiara S; Blair MP; Shapiro MJ; Lichtenstein SJ
    J AAPOS; 2013 Jun; 17(3):323-5. PubMed ID: 23607977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary intravitreal ranibizumab for high-risk retinopathy of prematurity.
    Baumal CR; Goldberg RA; Fein JG
    Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):432-8. PubMed ID: 25970863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferative retinopathy in Duchenne muscular dystrophy and its response to bevacizumab.
    Fagan XJ; Levy J; Al-Qureshi S; Harper CA
    Clin Exp Ophthalmol; 2012 Dec; 40(9):906-7. PubMed ID: 22594924
    [No Abstract]   [Full Text] [Related]  

  • 32. An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan.
    Wu WC; Kuo HK; Yeh PT; Yang CM; Lai CC; Chen SN
    Am J Ophthalmol; 2013 Jan; 155(1):150-158.e1. PubMed ID: 22967867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evidence-based meta-analysis of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 1. Retinopathy of prematurity.
    Mititelu M; Chaudhary KM; Lieberman RM
    J Pediatr Ophthalmol Strabismus; 2012; 49(6):332-40. PubMed ID: 22938516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.
    Kim J; Kim SJ; Chang YS; Park WS
    Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Surgical Management of Retinopathy of Prematurity Showing Rapid Progression despite Extensive Retinal Photocoagulation.
    Gadkari SS; Kulkarni SR; Kamdar RR; Deshpande M
    Middle East Afr J Ophthalmol; 2015; 22(3):393-5. PubMed ID: 26180484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.
    Travassos A; Teixeira S; Ferreira P; Regadas I; Travassos AS; Esperancinha FE; Prieto I; Pires G; van Velze R; Valido A; Machado Mdo C
    Ophthalmic Surg Lasers Imaging; 2007; 38(3):233-7. PubMed ID: 17552391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal low-dosage bevacizumab for retinopathy of prematurity.
    Harder BC; von Baltz S; Jonas JB; Schlichtenbrede FC
    Acta Ophthalmol; 2014 Sep; 92(6):577-81. PubMed ID: 24020921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central retinal vein obstruction in a neonate occurring during laser photocoagulation treatment for retinopathy of prematurity.
    Phalak D; Rani PK; Balakrishnan D; Jalali S
    J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e72-4. PubMed ID: 25427339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
    Dorta P; Kychenthal A
    Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.
    Kong L; Mintz-Hittner HA; Penland RL; Kretzer FL; Chévez-Barrios P
    Arch Ophthalmol; 2008 Aug; 126(8):1161-3. PubMed ID: 18695118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.